Dairy calves: pneumonia caused by Mycoplasma and/or Pasteurella multocida sensitive to tylosin.
Pigs: necrotic enteritis, enzootic pneumonia caused by organisms sensitive to tylosin. Broilers: chronic respiratory disease caused by organisms sensitive to tylosin.
Dairy calves: 40-50 mg of active ingredient/kg b.w. (equal to 20-25 g of product/100 kg of live weight) for 3-7 days;
Pigs: 10-12 mg of active ingredient/kg b.w. (equal to 5-6 g of product/100 kg of live weight) for 3-5 days;
Broilers: 25 mg of active ingredient/kg b.w. (equal to 12.5 g of product/100 kg of live weight) for 3-5 days.
The product must be administered in drinking water or liquid feed, according to the instructions of the prescribing veterinarian, taking care not to exceed the authorised daily dosage in mg of active ingredient/kg b.w.
The product is for oral use only. It is necessary to ensure that the treated animals have sufficient access to the water supply system to ensure adequate drinking water. No other water sources are available during the treatment period.
At the end of treatment, the water supply system must be properly cleaned to avoid ingestion of active ingredients below the therapeutic dose.
Do not use in animals with known hypersensitivity to tylosin or any of the excipients.
Do not use the product simultaneously with other macrolides or lincosamides.
Do not use in case of known resistance to tylosin or cross-resistance to other macrolides.
Do not use in animals suffering from hepatic damage.
Occasional cases of rectal mucosal edema with pruritus and erythema have been reported, especially in pigs. If serious adverse reactions or other reactions not mentioned in the leaflets occur, inform the responsible veterinarian.
Meat and offal:
Dairy calves: 24 days.
Pigs: 3 days.
Broilers: 12 days.
Not for use in animals producing or intended to produce eggs for human consumption.
Store below 30℃, in a dry place, and protect from light.